# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001628280-24-051956
Filing Date
2024-12-19
Accepted
2024-12-19 08:02:50
Documents
19
Period of Report
2024-12-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | aqst-20241219.htm iXBRL | 8-K | 28465
2 | EX-99.1 | aqstorphandrugdesignatio.htm | EX-99.1 | 16874
6 |  | aqstorphandrugdesignatio001.jpg | GRAPHIC | 277066
7 |  | aqstorphandrugdesignatio002.jpg | GRAPHIC | 240149
8 |  | aqstorphandrugdesignatio003.jpg | GRAPHIC | 197304
9 |  | aqstorphandrugdesignatio004.jpg | GRAPHIC | 280052
10 |  | aqstorphandrugdesignatio005.jpg | GRAPHIC | 148053
| Complete submission text file | 0001628280-24-051956.txt |  | 1749881

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | aqst-20241219.xsd | EX-101.SCH | 1776
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | aqst-20241219_lab.xml | EX-101.LAB | 21629
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | aqst-20241219_pre.xml | EX-101.PRE | 12504
21 | EXTRACTED XBRL INSTANCE DOCUMENT | aqst-20241219_htm.xml | XML | 2719

Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 241561017
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)